With all the new breakthroughs in cardiology with the removal of plaque, soon this could be a worry of the past. The product won’t be on the market until later this year. The process of “roto-rootering” plaque is making some huge leaps and bounds today to clear arteries and bring arterial related plaque disease to a slow down after treatment. BD
The Food and Drug Administration has approved Pathway Medical Technologies' "PV Atherectomy System," CEO Thomas Clement said in an interview today. Picture The system is designed to treat patients with peripheral artery disease by removing hard and soft diseased tissue and therefore restoring circulation in the peripheral arteries.
With all the new breakthroughs in cardiology with the removal of plaque, soon this could be a worry of the past. The product won’t be on the market until later this year. The process of “roto-rootering” plaque is making some huge leaps and bounds today to clear arteries and bring arterial related plaque disease to a slow down after treatment. BD
FDA approves Pathway Medical's system